NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · USD

SeaStar Medical Holding Corporation (ICUCW) Stock Analysis

SeaStar Medical Holding Corporation (ICUCW) is a stock listed on NASDAQ and quoted in US Dollar.

ICUCW

$0.02

−$0.00 (−0.61%)

Sep 4, 2026 · Market close

This is a derivative instrument — a warrant on SeaStar Medical Holding Corporation (ICUC) common stock.

Issuer fundamentals are shown on the issuer page, not here.

Price History

Hover for the daily close. The dotted line marks the period open.

ICUCW Key Statistics

As of Sep 4, 2026
Trading
Open
$0.04
Previous Close
$0.02
Day's Range
0.02–0.02
52-Week Range
0.02–0.02
Volume
11.95K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
−1.04

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

ICUCW Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+32.79%
2025 (partial year)+0.00%

As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

About SeaStar Medical Holding Corporation

SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.

Visit website →